NEW YORK, Aug 12 (GenomeWeb News) - Invitrogen said today that it will provide Exelixis with validated high-throughput screening assays for drug discovery in single live cells, which Exelixis will use for lead discovery and optimization.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.